Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-01-14

Clinical Trial Update: New Methods to Measure the Immune Response to Hepatitis B Vaccine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating methods to measure immune response to Hepatitis B vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oxford | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED